NCT04118270View on ClinicalTrials.gov

Shared Decision-Making: AFib 2gether Mobile App

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

June 26, 2020

Study Completion Date

June 26, 2020

Conditions
Atrial Fibrillation New Onset
Interventions
DEVICE

Afib 2gether TM Mobile Application

The Afib 2gether mobile app determines a patient's stroke risk through a series of questions that the patient will answer in the app.

Trial Locations (1)

01655

UMass Medical School, Worcester

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Massachusetts, Worcester

OTHER

NCT04118270 - Shared Decision-Making: AFib 2gether Mobile App | Biotech Hunter | Biotech Hunter